Alexander disease with mild dorsal brainstem atrophy and infantile spasms

Hiroyuki Torisu1, Yoko Yoshikawa, Yui Yamaguchi-Takada

  • 1Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. htorys@pediatr.med.kyushu-u.ac.jp

Brain & Development
|July 24, 2012
PubMed

Insights

This study details a rare case of infantile spasms in a Japanese infant with Alexander disease, a genetic neurological disorder. Treatment with lamotrigine effectively managed the spasms and improved EEG findings.

Area of Science:

  • Neuroscience
  • Genetics
  • Pediatrics

Background:

  • Alexander disease is a rare genetic leukoencephalopathy characterized by astrogliosis.
  • Infantile spasms, a severe epilepsy syndrome, are uncommon in Alexander disease patients.

Observation:

  • A Japanese male infant presented with hypotonia, developmental delay, and partial seizures.
  • Brain MRI confirmed Alexander disease criteria, showing pontomedullary atrophy and abnormal intensities.
  • Genetic analysis revealed a novel GFAP gene mutation (c.1154 C>T, p.S385F).

Findings:

  • The infant developed infantile spasms at 8 months of age with hypsarrhythmia on EEG.
  • Lamotrigine treatment successfully controlled the spasms and normalized EEG abnormalities.
  • This case highlights a rare comorbidity in infantile Alexander disease.

Implications:

  • The specific brain lesion distribution and age of onset may influence the development of infantile spasms in Alexander disease.
  • This case expands the understanding of epilepsy phenotypes in Alexander disease.
  • Early diagnosis and targeted treatment are crucial for managing comorbid conditions in rare neurological disorders.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...